AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 46 filers reported holding AADI BIOSCIENCE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,868,101 | -30.0% | 1,005,806 | -1.1% | 0.00% | – |
| Q2 2023 | $6,957,128 | +9.7% | 1,017,124 | +16.1% | 0.00% | – |
| Q1 2023 | $6,343,435 | -44.6% | 876,165 | -1.8% | 0.00% | – |
| Q4 2022 | $11,442,602 | -5.7% | 891,863 | +3.9% | 0.00% | – |
| Q3 2022 | $12,130,000 | +9.1% | 858,502 | -4.9% | 0.00% | – |
| Q2 2022 | $11,121,000 | +111.3% | 902,677 | +191.1% | 0.00% | – |
| Q1 2022 | $5,263,000 | -29.6% | 310,127 | +0.2% | 0.00% | – |
| Q4 2021 | $7,475,000 | +1463.8% | 309,554 | +1804.9% | 0.00% | – |
| Q3 2021 | $478,000 | – | 16,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $193,062 | 17.76% |
| Alerce Investment Management, L.P. | 1,630,830 | $11,807,209 | 15.60% |
| ACUTA CAPITAL PARTNERS, LLC | 1,849,402 | $13,389,670 | 9.86% |
| Decheng Capital Management III (Cayman), LLC | 526,329 | $3,810,622 | 1.54% |
| Knott David M Jr | 183,688 | $1,330 | 0.52% |
| Vivo Capital, LLC | 509,572 | $6,456,277 | 0.45% |
| Ghost Tree Capital, LLC | 150,000 | $1,086,000 | 0.32% |
| Avoro Capital Advisors LLC | 2,849,402 | $20,629,670 | 0.31% |
| Parkman Healthcare Partners LLC | 75,961 | $549,958 | 0.12% |
| RA Capital Management | 590,218 | $4,273,178 | 0.10% |